Danaher (DHR) CEO says there's modest recovery in pharmaceutical, especially in Europe; academic and research demand is fairly muted in USA and China, though generally stable
Importance
Level 1
#UNITED STATES#DANAHER CORP#DHR.US#EQUITIES#EU SESSION#US SESSION#LIFE SCIENCES TOOLS & SERVICES#LIFE SCIENCES TOOLS & SERVICES (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#DHR#US EQUITIES#CHINA